Search earnings tickers

ABBV

2024Q4BMO

AbbVie Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-01-31 · Fiscal end 2024-12-31 · Features as of 2025-01-30

← Earnings history

Street

Consensus EPS2.12

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move1.6%

IV front—

P/C full—

P/C front—

Features as of2025-01-30

Run-up

Close—

Ret 5d+2.9%

Ret 10d+2.5%

Ret 20d-0.3%

Ret 30d+1.3%

Print

Actual EPS

2.16Beat

Estimated EPS2.12

Actual revenue

15.1B

Surprise %+1.9%

Beat / missBeat

Beat streak 42

Beat streak 82

Reaction

1-day stock reaction-1.8%

Implied vs actual

Implied 1.6%Actual 6.6%

Gap reaction+6.6%

Day result+4.7%

Next-day upNo

Realized / IV4.12×

Post tape

Post 5d+3.6%

Post 10d+4.9%

Post volume11.9M

Vol ×10d1.85×

Vol ×20d2.06×

Post range4.3%